F Star Therapeutics Inc (FSTX) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
F star Therapeutics Inc   (NASDAQ: FSTX)


F Star Therapeutics Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is F Star Therapeutics Inc 's ROA in the third quarter of 2022?
F Star Therapeutics Inc recorded a cumulative net loss of $-44 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -42.39%.

However, within the Healthcare sector 676 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2022 from 4694 to 4728.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Total Assets Change -26.62 % -17.48 % 117.73 % 93.4 % 325.74 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -44 -37 -34 -31 -42
Return On Assets (TTM) -42.39 % -32.78 % -28.46 % -30.55 % -47.8 %
FSTX's Total Ranking # 4728 # 4694 # 4558 # 4933 # 4357
Total Assets (TTM) in million 83 100 113 123 113
Seq. Total Assets Change -17.57 % -11.28 % -7.96 % 9.02 % -7.3 %
Seq. Net Income Change - - - - -

FSTX's 5 Years Annual ROA >> Back to FSTX Management Effectiveness >> Compare FSTX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 288
Sector # 677
Overall # 4629

Return On Assets Statistics
High Average Low
-28.06 %
-49.76 %
-91.32 %
(Mar 31 2022)   (Dec 31 2016)





Financial Statements
F Star Therapeutics Inc 's Assets $ 83 million FSTX's Balance sheet
F Star Therapeutics Inc 's Income $ -18 million Quarterly FSTX's Income Statement
FSTX's Income by Division See FSTX's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change 93.4 % 0.65 % -8.16 % 31.47 % 94.73 %
Total Assets in million 123 64 63 69 52
Y / Y Net Income Change - - - - -
Net Income in million -31 -26 -24 -23 -28
Annual Return On Assets -25.43 % -40.28 % -38.13 % -33.21 % -52.88 %

FSTX's 5 Years Annual ROA >> Back to FSTX Management Effectiveness >> Compare FSTX ROA to its Competitors



More Return On Assets Ratios
FSTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FSTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FSTX's Competitors
Subscribers only: Roa for F Star Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for FSTX's Customers

You may also want to know
FSTX's Roi FSTX's Inventory Turnover Ratio FSTX's Growth Rates FSTX's Dividend Comparisons
FSTX's Profitability Ratios FSTX's Asset Turnover Ratio FSTX's Dividend Growth
FSTX's Roe FSTX's Valuation Ratios FSTX's Financial Strength Ratios FSTX's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.